DCPT1061

• CAT Number: I040153
• CAS Number: 2289726-31-2
• Molecular Formula: C17H20Cl2N2O
• Molecular Weight: 339.26
• Purity: ≥95%
• Synonyms: N’-[[2-(2,3-dichlorophenoxy)phenyl]methyl]-N,N’-dimethylethane-1,2-diamine
• InChI: InChI=1S/C17H20Cl2N2O/c1-20-10-11-21(2)12-13-6-3-4-8-15(13)22-16-9-5-7-14(18)17(16)19/h3-9,20H,10-12H2,1-2H3
• InChIKey: GCURTAFSSBAXNO-UHFFFAOYSA-N
• SMILES: CNCCN(C)CC1=CC=CC=C1OC2=C(C(=CC=C2)Cl)Cl

DCPT1061 (Cat No.:  I040153) is a small-molecule compound under investigation for its potential therapeutic applications, particularly in oncology. It targets specific signaling pathways involved in cancer cell survival, proliferation, and metastasis. The compound shows promise in modulating key proteins or enzymes within tumor cells, potentially enhancing the effectiveness of cancer treatments. While detailed mechanisms of action are still being explored, DCPT1061’s ability to interfere with cancer cell growth and overcome resistance mechanisms positions it as a promising candidate for further development in cancer therapy.

Reference

[1]. Jianfeng Wang, et al. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Theranostics. 2021 Mar 12;11(11):5387-5403.
[Content Brief]

[2]. Hongru Tao, et al. PRMT1 inhibition activates the interferon pathway to potentiate antitumor immunity and enhance checkpoint blockade efficacy in melanoma. Cancer Res. 2023 Nov 22.
[Content Brief]